Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00000318

Enrollment

202

Registered

1999-09-21

Start date

1994-12-31

Completion date

2007-08-31

Last updated

2017-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Related Disorders, Substance-Related Disorders

Keywords

opioid dependence

Brief summary

The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.

Interventions

DRUGBuprenorphine

1. Experimental Maintenance treatment with daily medication 2. Experimental Maintenance treatment with thrice-weekly medication

Study design

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to 55 Years

Healthy volunteers

Inclusion criteria

Please contact site for information.

Design outcomes

Primary

Measure	Time frame
Opioid and cocaine use	26 weeks
Social and psychological functioning	26 weeks
AIDS risk behavior	26 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026